A Novel ROS1-FBXL17 Fusion Co-Existing with CD74-ROS1 Fusion May Improve Sensitivity to Crizotinib and Prolong Progression-Free Survival of Patients with Lung Adenocarcinoma

Lan S, Li H, Liu Y, Xu J, Huang Z, Yan S, Zhang Q, Cheng Y

OncoTargets and Therapy 2020, 13:11499-11504

Published Date: 10 November 2020